Pfizer Fined For Hiking Epilepsy Drug Price 2,600-Percent In UKBritish regulators fined U.S. drugmaker Pfizer and distributor Flynn Pharma a record $112.7 million Wednesday for increasing the cost of an epilepsy drug by as much as 2,600 percent.
Bristol-Myers Drug Fails Lung Cancer Study, Shares PlungeA blockbuster cancer treatment failed in a key study as the drug's maker, Bristol-Myers Squibb, attempts to extend its usage to lung cancer patients.
Field Of Sexual Medicine Tightly Intertwined With Pharmaceutical IndustryHow do you measure sexual desire? If you're a drugmaker trying to win approval for a medication to boost female libido, it might come down to two questions on a medical questionnaire.
2 Texas Patients Who Received Recalled Drug Die Texas health officials say no link has been found between a compounded drug and the death of two patients who developed blood infections after receiving it before its recall.
Drug Safely Cuts Prostate Cancer Risk, Texas Study FindsThe results of a long-term major federal study that was done in Texas is easing worries about the safety of a hormone-blocking drug that can lower a man's chances of developing prostate cancer.
Court: Can Drug Companies Pay To Delay Generics? Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs.
Alzheimer's Drug Fails Study But Flashes Potential An Alzheimer's treatment from Eli Lilly and Co. failed to slow memory decline in two separate patient studies, but the drug did show some potential to help in mild cases of the mind-robbing condition that is notoriously difficult to treat.
Tarrant Co. Prepares For Drug "Take-Back" EventA drug "take-back" program in Tarrant County has netted a huge stash of old medications. Organizations across Tarrant County have had three take-back events since 2010 and another is slated for later this month.